House dust mite allergy extract (Stallergenes)

屋尘螨变应原提取物 (Stallergenes)

Report date: 2026/05/13 20:02:10

Base Information

Drug NameHouse dust mite allergy extract (Stallergenes)
Drug Alias NameHouse dust mite sublingual immunotherapy屋尘螨过敏免疫疗法House dust mite allergy immunotherapyHouse dust mite SLITOralair Mites +[14] 
ClassificationBiologics > Antigen > Allergen extract
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsHypersensitivityConjunctivitisRhinitis, Allergic, Perennial +[4] 
Global Approved IndicationsRhinitis, Allergic, Perennial
Approved Indications in ChinaN/A
Original Approved Country/TerritoryJapan
Original Approved Date2015/03/26
Country/TerritoryUnited StatesFranceMainland China +[4] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesSa Stallergenes
China Registration ClassN/A

Develop Information

Active CompaniesStallergenes SaNuance Pharma Ltd
Inactive CompaniesStallergenes Greer
Active IndicationsConjunctivitisRhinitis, Allergic, PerennialRhinitis, Allergic
Inactive IndicationsHypersensitivity

Other Information

ATC CodeV01AA03
Related LinksN/A